Applications are now open! Please submit a Full Application by October 15, 2026.
- Improving Guideline Concordant Care for Advanced HER2+ GEA in the United States
The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant care for patients with HER2+ GEA in the United States, including the administration of HER 2 directed therapy as part of first line treatment. The total funding available for this RFP is $1,000,000. Individual projects requesting up to $125,000 USD over a two-year period will be considered.
For more information about this funding opportunity, please click here, or download the Request for Proposals (RFP) here.
If you have questions regarding this RFP, please direct them in writing to Andrew L. Smith, PhD (Andrew.Smith@conquer.org) and Caroline DiCristo, PharmD (Caroline.DiCristo@jazzpharma.com).
- Improving Guideline-Concordant Glioma Molecular Testing and Treatment in the United States
The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant molecular testing and care for pediatric and adult glioma in the United States. The total funding available for this RFP is $1,000,000. Individual projects requesting up to $125,000 USD over a two-year period will be considered.
For more information about this funding opportunity, please click here, or download the Request for Proposals (RFP) here.
If you have questions regarding this RFP, please direct them in writing to Andrew L. Smith, PhD (Andrew.Smith@conquer.org) and Nicholas E. Wojtynek, PhD (Nicholas.Wojtynek@jazzpharma.com).
These Quality Improvement grant initiatives are a collaboration between Jazz Pharmaceuticals and EveryGrant® powered by Conquer Cancer, designed expressly to meet the needs of patients with cancer and care providers. Conquer Cancer acts as the primary administrator for the review and evaluation of applications. Grant funding will be provided directly to recipients by Jazz Pharmaceuticals.
To start an application, you must create an account by clicking Register at the top right-hand corner of the page and following the instructions on the next page.
If you already have an account, click Log-in.
Under Programs, select the Jazz Quality Improvement Grants and click Apply.
Jazz Quality Improvement Grants
Applications are now open! Please submit a Full Application by October 15, 2026.
- Improving Guideline Concordant Care for Advanced HER2+ GEA in the United States
The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant care for patients with HER2+ GEA in the United States, including the administration of HER 2 directed therapy as part of first line treatment. The total funding available for this RFP is $1,000,000. Individual projects requesting up to $125,000 USD over a two-year period will be considered.
For more information about this funding opportunity, please click here, or download the Request for Proposals (RFP) here.
If you have questions regarding this RFP, please direct them in writing to Andrew L. Smith, PhD (Andrew.Smith@conquer.org) and Caroline DiCristo, PharmD (Caroline.DiCristo@jazzpharma.com).
- Improving Guideline-Concordant Glioma Molecular Testing and Treatment in the United States
The intent of this RFP is to request proposals for the implementation of strategies that will support and measurably improve equitable delivery of guideline concordant molecular testing and care for pediatric and adult glioma in the United States. The total funding available for this RFP is $1,000,000. Individual projects requesting up to $125,000 USD over a two-year period will be considered.
For more information about this funding opportunity, please click here, or download the Request for Proposals (RFP) here.
If you have questions regarding this RFP, please direct them in writing to Andrew L. Smith, PhD (Andrew.Smith@conquer.org) and Nicholas E. Wojtynek, PhD (Nicholas.Wojtynek@jazzpharma.com).
These Quality Improvement grant initiatives are a collaboration between Jazz Pharmaceuticals and EveryGrant® powered by Conquer Cancer, designed expressly to meet the needs of patients with cancer and care providers. Conquer Cancer acts as the primary administrator for the review and evaluation of applications. Grant funding will be provided directly to recipients by Jazz Pharmaceuticals.
To start an application, you must create an account by clicking Register at the top right-hand corner of the page and following the instructions on the next page.
If you already have an account, click Log-in.
Under Programs, select the Jazz Quality Improvement Grants and click Apply.